Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eyedea Medtech is a French medical technology company specializing in innovative solutions for corneal transplantation. The company's flagship product, Endo-K, is a patented medical device designed to simplify and standardize Descemet Membrane Endothelial Keratoplasty (DMEK) procedures. By facilitating the preparation and insertion of the corneal graft, Eyedea Medtech aims to improve surgical outcomes and reduce the complexity of treating endothelial diseases. The company's technology was born from clinical research at the Rouen University Hospital and is now used by ophthalmic surgeons globally. Eyedea Medtech focuses on enhancing the efficiency of eye banks and surgical centers through specialized instrumentation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eyedea Medtech.